Browsing: Advanced therapies

biomarker-schizophrenia
0

Researchers from the RIKEN Center for Brain Science (Wako, Japan) have identified that hydrogen sulfide production – as a result of MPST gene expression – was higher in postmortem brains from individuals with schizophrenia compared with unaffected individuals.

biosensor-pacifier
0

Scientists from the University of California San Diego (CA, USA) and the University of Alcalá (Madrid, Spain) have reported a pacifier biosensor that could pave the way for future research towards noninvasive saliva biomarker monitoring.

CAR-T
0

In this feature, we will be investigating chimeric antigen receptor T-cell therapies, their benefits and potential side effects, and what the future may hold for the development of this type of immunotherapy treatment.

3D-cells-purple_RGB
0

In this interview, David Harris (Charles River Laboratories; NC, USA) discusses the current global landscape for cell therapy, associated safety concerns and challenges, and preclinical animal models that are used to evaluate cellular therapies.

CAR-T
0

Discover more about the development of CAR-T cell therapies, their bioanalytical challenges and specialized antibody reagents that can be ustilized to overcome these in this interview with Michael Schwenkert (Bio-Rad Laboratories; Germany).

1 2